Summary
TDAC Chart
Translational Development Acquisition Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| DB David Barlow Glazer Capital LLC | 390,245 | $3.93M | $3.93M | -$65.8 | - |
| SK Steven Katznelson Radcliffe Capital Management LP | 271,940 | $2.82M | $2.91M | $90,955.37 | 3.23% |
| VL Vincent Leva Linden Advisors LP | 1.15M | $11.93M | $12.29M | $366,000 | 3.07% |
| BO Brian Oliveira Clear Street Group Inc. | 4,963 | $52,384.58 | $51,366.67 | -$1,017.91 | -1.94% |
Translational Development Acquisition Corp. (TDAC) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Translational Development Acquisition Corp. Profile
| Trading Companies & Distributors Industry | Industrials Sector | Michael Hoffman CEO | NASDAQ (NMS) Exchange | G9008W105 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Translational Development Acquisition Corp. is a company that has set its sights on becoming a pivotal player in the business world by engaging in various strategic activities aimed at growth through consolidation. Founded in 2022 and headquartered in New York, New York, the company's primary objective is to seek out and complete a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. This approach highlights its role as a facilitator of business expansion and restructuring, offering a platform for other companies to scale, evolve, or enhance their operational efficiencies through strategic partnerships and combinations.
Products and Services
- Merger and Acquisition Facilitation
- Amalgamation and Share Exchange Services
- Asset Acquisition and Share Purchase Agreements
- Reorganization and Business Combination Solutions
Translational Development Acquisition Corp. specializes in serving as a catalyst for significant corporate transformations through mergers and acquisitions. This service encompasses the identification of potential merger partners, negotiation of terms, and facilitation of the merger or acquisition process. The objective is to create synergies that benefit the combined entity in terms of market share, operational efficiency, and financial strength.
The company offers expertise in the intricate processes of amalgamation and share exchange, which are essential for businesses looking to combine their operations without losing their essence. This includes legal and financial structuring, ensuring that the amalgamation or share exchange is conducted smoothly and effectively, with an eye toward maximizing shareholder value and creating a stronger, more competitive enterprise.
In situations where a full merger or amalgamation is not feasible or desired, Translational Development Acquisition Corp. provides services for asset acquisition and share purchase. This allows companies to acquire specific assets or shares from another company, thereby expanding their capabilities or market presence without undergoing a complete merger. This service is tailored to ensure a beneficial arrangement for both the buyer and the seller, focusing on strategic growth and investment recovery.
The company also extends its expertise to reorganization and other forms of business combinations, which can be vital for companies needing to refocus their business strategies, optimize operational structures, or improve financial health. By guiding businesses through the reorganization process or by facilitating more complex business combinations, Translational Development Acquisition Corp. seeks to enhance the underlying value and competitiveness of the entities involved.
Contact Information
